Latin American emerging economies have become a focus for Big Pharma investment, with a number of significant investment projects announced this year
Events on Wednesday 04th July 2012:
World Cities Summit 2012
The World Cities Summit (WCS) is an exclusive and premier platform for government leaders and industry experts to address liveable and sustainable city challenges, share integrated urban solutions and forge new partnerships.
Sunday 01 July 2012 09:30 - Wednesday 04 July 2012 17:30 - Hall B, Level 1, Sands Expo & Convention Centre, Marina Bay SandsJuly 2012:
1 Jul |
World Cities Summit 2012
Themed “Liveable and Sustainable Cities – Integrated Urban Solutions”, the 2012 edition will see global leaders exploring how cities can build resilience, improve their quality of life and the environment. The Summit will be held in Singapore, a strategic location in the Asia Pacific region. Building on the success of the previous Summits, WCS 2012 is expected to attract more than 3,000 policy makers, business leaders and industry experts from around the world. www.worldcitiessummit.com.sg |
Latest articles from Events
Following the smart money
Biotech companies can only thrive with the right mix of available funding, intellectual property protection and effective regulation. With so many locations claiming to offer them all, an fDi panel discusses how companies can best evaluate expansion options
MIPIM round-up
Courtney Fingar canvasses a selection of Europe’s political leaders at the 2009 Mipim event in Cannes to find out how they are facing up to the challenges posed to attracting investment in the current economic climate.
Editor's note: Raise a glass to more sober times
There was less of a party atmosphere at this year’s Mipim event – just as well for one delegate – but the end of the heady days shouldn’t be mourned, for such austere times are when the clear-headed thrive, and those nursing a hangover get left behind, writes Courtney Fingar.
Big pharma gets bigger
The trend for amalgamation within the pharmaceutical sector is creating ever bigger and stronger companies, writes Lara Williams.
Shanghai for science
Heading up fDi’s rankings for medical device manufacturing are Shanghai, New York and Istanbul – with Shanghai also topping the quality rankings for life sciences R&D.
An eye on expansion
The global of president Bausch & Lomb’s pharmaceutical division tells Lara Williams how the company’s global presence has helped it defy the economic slowdown, and that it now has Asia-Pacific, eastern Europe and Latin America in its sights.
Pharma giants target Africa
GlaxoSmithKline poised to take 10% share in Aspen as Western drug companies target emerging economies.n
Real optimism
The gloom surrounding global markets hasn’t prevented Cushman & Wakefield CEO Bruce Mosler from looking towards a bright future. He tells Lara Williams why the company’s prospects for 2009 show some light at the end of the tunnel
Unlocking capital
In these troubled economic times, sale and leaseback transactions can provide companies with much-needed cash flow, writes Lara Williams.
« Previous 1 2
Crossborder investment monitor
|
fDi Markets is the only online database tracking crossborder greenfield investment covering all sectors and countries worldwide. It provides real-time monitoring of investment projects, capital investment and job creation with powerful tools to track and profile companies investing overseas.
Corporate location benchmarking tool
fDi Benchmark is the only online tool to benchmark the competitiveness of countries and cities in over 50 sectors. Its comprehensive location data series covers the main cost and quality competitiveness indicators for over 300 locations around the world.
Research report
fDi Intelligence provides customised reports and data research which deliver vital business intelligence to corporations, investment promotion agencies, economic development organisations, consulting firms and research institutions.
Find out more.